Scarica l'app Stockscreener
192.22
0.15%
-0.29
Dopo l'orario di chiusura:
192.22
Precedente Chiudi:
$192.51
Aprire:
$194.72
Volume 24 ore:
1.11M
Relative Volume:
0.90
Capitalizzazione di mercato:
$26.38B
Reddito:
$1.96B
Utile/perdita netta:
$-253.24M
Rapporto P/E:
-101.10
EPS:
-1.9012
Flusso di cassa netto:
$94.06M
1 W Prestazione:
+1.92%
1M Prestazione:
+17.95%
6M Prestazione:
+24.99%
1 anno Prestazione:
+63.36%
Intervallo 1D:
$189.38
$195.44
Intervallo di 1 settimana:
$183.88
$198.99
Portata 52W:
$117.27
$198.99
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Confronta NTRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
192.22 | 26.42B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
563.78 | 216.18B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
221.01 | 157.52B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
647.40 | 51.27B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.59 | 41.97B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
217.43 | 37.49B | 15.70B | 1.24B | 2.01B | 6.9036 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
What analysts say about Natera Inc stockTrade Execution Strategies & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Natera’s New Study: A Potential Game-Changer in Breast Cancer Treatment - TipRanks
Using portfolio simulators with Natera Inc. includedTake Profit & Real-Time Chart Pattern Alerts - newser.com
Will Natera Inc. stock outperform Nasdaq indexJuly 2025 Short Interest & AI Based Buy and Sell Signals - newser.com
Natera’s FIND-CRC Study: A Potential Game-Changer in Colorectal Cancer Screening - TipRanks
Natera Inc.’s Innovative Approach to Heart Transplant Rejection Monitoring: A Study Update - TipRanks
Natera’s PROCEED-CRC Study: A Step Forward in Early Cancer Detection - TipRanks
How Investors May Respond To Natera (NTRA) Signatera Data Boosting FDA Case in Bladder Cancer - simplywall.st
November 2026 Options Now Available For Natera (NTRA) - Nasdaq
How high can Natera Inc. stock goRate Hike & Weekly Watchlist of Top Performers - newser.com
Is Natera Inc. stock positioned well for digital economyJuly 2025 Chart Watch & Risk Adjusted Buy and Sell Alerts - newser.com
Regression analysis insights on Natera Inc. performanceCEO Change & Daily Entry Point Alerts - newser.com
Published on: 2025-10-27 06:35:18 - newser.com
Why Natera Inc. stock could see breakout soonQuarterly Trade Summary & High Yield Stock Recommendations - newser.com
Published on: 2025-10-27 05:35:59 - newser.com
Halper Sadeh LLC Encourages Natera Inc. Shareholders to Contact the Firm to Discuss Their Rights - The Joplin Globe
Price momentum metrics for Natera Inc. explainedRate Hike & Weekly High Conviction Ideas - newser.com
Ranking Natera Inc. among high performing stocks via toolsPortfolio Value Report & Safe Swing Trade Setups - newser.com
Key resistance and support levels for Natera Inc.Weekly Trade Recap & High Return Trade Opportunity Guides - newser.com
Automated trading signals detected on Natera Inc.Weekly Trade Recap & AI Powered Market Entry Ideas - newser.com
Published on: 2025-10-25 22:46:18 - newser.com
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):